PubRank

B Thorsteinsson

Author PubWeight™ 46.48‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabet Med 1991 1.93
2 Frequency and risk factors of severe hypoglycaemia in insulin-treated Type 2 diabetes: a cross-sectional survey. Diabet Med 2006 1.86
3 Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr 1992 1.52
4 Glucose tolerance in patients with cystic fibrosis: five year prospective study. BMJ 1995 1.50
5 Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections. Acta Paediatr 1994 1.50
6 Nocturnal hypoglycaemia in patients receiving conventional treatment with insulin. Br Med J (Clin Res Ed) 1985 1.47
7 The Somogyi phenomenon revisited using continuous glucose monitoring in daily life. Diabetologia 2005 1.44
8 Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatr 1994 1.34
9 The relationship between symptomatic and biochemical hypoglycaemia in insulin-dependent diabetic patients. J Intern Med 1990 1.15
10 Cognitive function during hypoglycaemia in type I diabetes mellitus. Br Med J (Clin Res Ed) 1986 1.15
11 Glycaemic threshold for changes in electroencephalograms during hypoglycaemia in patients with insulin dependent diabetes. Br Med J (Clin Res Ed) 1988 1.14
12 A 6-year nationwide cohort study of glycaemic control in young people with type 1 diabetes. Risk markers for the development of retinopathy, nephropathy and neuropathy. Danish Study Group of Diabetes in Childhood. J Diabetes Complications 2001 1.10
13 Modeling absorption kinetics of subcutaneous injected soluble insulin. J Pharmacokinet Biopharm 1989 1.09
14 Frequency and motives of blood glucose self-monitoring in type 1 diabetes. Diabetes Res Clin Pract 2009 1.04
15 Hypoglycaemia during pregnancy in women with Type 1 diabetes. Diabet Med 2012 1.04
16 Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance. Acta Endocrinol (Copenh) 1993 1.02
17 Insulin analogues and severe hypoglycaemia in type 1 diabetes. Diabetes Res Clin Pract 2011 1.01
18 Renal threshold for glucose in non-insulin-dependent diabetic patients. Diabetes Res Clin Pract 1997 1.00
19 Activity of angiotensin-converting enzyme and risk of severe hypoglycaemia in type 1 diabetes mellitus. Lancet 2001 0.99
20 Glucose tolerance in cystic fibrosis. Arch Dis Child 1991 0.98
21 Metabolic control and prevalence of microvascular complications in young Danish patients with Type 1 diabetes mellitus. Danish Study Group of Diabetes in Childhood. Diabet Med 1999 0.95
22 Impaired glucose tolerance and diabetes mellitus in elderly subjects. Diabetes Care 1987 0.94
23 Reproducibility and reliability of hypoglycaemic episodes recorded with Continuous Glucose Monitoring System (CGMS) in daily life. Diabet Med 2005 0.92
24 Lower levels of circulating IGF-I in Type 1 diabetic women with frequent severe hypoglycaemia during pregnancy. Diabet Med 2008 0.89
25 Prediction of severe hypoglycaemia by angiotensin-converting enzyme activity and genotype in type 1 diabetes. Diabetologia 2002 0.89
26 Frequency of daytime biochemical hypoglycaemia in insulin-treated diabetic patients: relation to daily median blood glucose concentrations. Diabet Med 1986 0.88
27 Diabetes mellitus in cystic fibrosis: genetic and immunological markers. Acta Paediatr 1993 0.85
28 Effects of insulin on renal haemodynamics and sodium handling in normal subjects. Scand J Clin Lab Invest 1991 0.85
29 NT-pro-BNP during hypoglycemia and hypoxemia in normal subjects: impact of renin-angiotensin system activity. J Appl Physiol (1985) 2008 0.84
30 Absorption of soluble and isophane semi-synthetic human and porcine insulin in insulin-dependent diabetic subjects. Acta Endocrinol (Copenh) 1984 0.84
31 A reevaluation of atrial fibrillation in thyrotoxicosis. Dan Med Bull 1984 0.83
32 Endocrine and exocrine pancreatic function and the delta F508 mutation in cystic fibrosis. Clin Genet 1991 0.83
33 Study rationale and design of the CIMT trial: the Copenhagen Insulin and Metformin Therapy trial. Diabetes Obes Metab 2009 0.83
34 Insulin sensitivity and insulin clearance in cystic fibrosis patients with normal and diabetic glucose tolerance. Clin Endocrinol (Oxf) 1994 0.82
35 Evaluating the cost-effectiveness of reduced mild hypoglycaemia in subjects with Type 1 diabetes treated with insulin detemir or NPH insulin in Denmark, Sweden, Finland and the Netherlands. Diabet Med 2012 0.80
36 Varenicline may trigger severe hypoglycaemia in Type 1 diabetes. Diabet Med 2008 0.80
37 Prospective and retrospective recording of severe hypoglycaemia, and assessment of hypoglycaemia awareness in insulin-treated Type 2 diabetes. Diabet Med 2009 0.79
38 [A prospective study of back complaints in recruits]. Ugeskr Laeger 1982 0.78
39 Long-term insulin-dependent diabetes mellitus with secondary pituitary insufficiency and regression of retinopathy. Acta Med Scand 1983 0.78
40 A high concentration of prorenin in early pregnancy is associated with development of pre-eclampsia in women with type 1 diabetes. Diabetologia 2011 0.78
41 The relationship between plasma concentration and plasma disappearance rate of immunoreactive insulin in normal subjects. Diabetologia 1982 0.77
42 Association between plasma activities of semicarbazide-sensitive amine oxidase and angiotensin-converting enzyme in patients with type 1 diabetes mellitus. Diabetologia 2005 0.77
43 Severe hypoglycaemia during pregnancy in women with type 1 diabetes: possible role of renin-angiotensin system activity? Diabetes Res Clin Pract 2009 0.77
44 Iodine-induced hyperthyroidism and bronchial asthma. Lancet 1977 0.77
45 Insulin/C-peptide response to intravenous glucagon. A dose-response study in normal and non-insulin-dependent diabetic subjects. Acta Endocrinol (Copenh) 1988 0.77
46 [Pituitary function in hemochromatosis]. Ugeskr Laeger 1996 0.77
47 Non-linearity of insulin kinetics. Diabetologia 1986 0.76
48 Erythropoietin and vascular endothelial growth factor as risk markers for severe hypoglycaemia in type 1 diabetes. Eur J Endocrinol 2010 0.75
49 The incidence of severe hypoglycaemia in pregnant women with type 1 diabetes mellitus can be reduced with unchanged HbA1c levels and pregnancy outcomes in a routine care setting. Diabetes Res Clin Pract 2013 0.75
50 [Back complaints among Danish recruits]. Ugeskr Laeger 1982 0.75
51 Kinetic models for insulin disappearance from plasma in type I diabetic patients. Pharmacol Toxicol 1987 0.75
52 [Ephedrine in the treatment of obesity. A double-blind cross-over trial of the effect of Elsinore tablets]. Ugeskr Laeger 1980 0.75
53 [Iodine-induced thyrotoxicosis]. Ugeskr Laeger 1979 0.75
54 [Insulin shock treated at casualty departments. A retrospective analysis of 120 episodes]. Ugeskr Laeger 1986 0.75
55 Subcutaneous absorption of U-40 and U-100 insulin. Horm Metab Res 1984 0.75
56 The C-peptide response to glucagon injections in IDDM and NIDDM patients. Horm Metab Res 1985 0.75
57 ACTH stimulation test in patients with type 1 diabetes and recurrent severe hypoglycaemia. Clin Endocrinol (Oxf) 2014 0.75
58 [Plasma concentrations of C-peptide and glucose during glucose tolerance tests. The effects of running]. Ugeskr Laeger 1985 0.75
59 Diabetes care: a guideline to the facilities needed to support internationally endorsed standards. Diabet Med 1995 0.75
60 The content of water and potassium in fat cells. Biochim Biophys Acta 1976 0.75
61 Correlation between the routine 6-min. C-peptide value and the AUC after I.V. glucagon injection in NIDDM patients. Horm Metab Res 1982 0.75
62 [Glucose tolerance in patients with cystic fibrosis]. Ugeskr Laeger 1996 0.75
63 [Pneumococcal vaccination and diabetes]. Ugeskr Laeger 1997 0.75
64 Kinetic models for plasma disappearance of insulin in normal subjects. Acta Pharmacol Toxicol (Copenh) 1985 0.75
65 Kinetics of insulin disappearance from plasma in cortisone-treated normal subjects. Clin Endocrinol (Oxf) 1987 0.75
66 Pharmacokinetics of intermediate-acting insulins: tracer studies. Neth J Med 1985 0.75